Iovance Biotherapeutics is pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient
Iovance Biotherapeutics is pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The company focuses on tumor infiltrating lymphocyte (TIL) therapy, which involves collecting and growing a patient’s TIL outside the body to be administered back as a one-time treatment.